Feasibility study assesses health-related quality of life in pediatric oncology, suggesting need for further exploration.
Routine assessment of HRQoL using an ePROM platform was feasible, acceptable, and usable for children aged 5-12 years with cancer. Preliminary evidence suggesting clinical utility supports the need for future implementation-effectiveness studies.
No takes yet. Share an insight, caveat, or question.
Doig et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: